Abion (203400.KQ) Stock Price

Abion Price

CLOSED
676.00
​
Market closed

Revenue at Abion has contracted by 15.0% per year over the past 9 years to 880.14 M KRW. Abion's net margin stands at -3,302.2%, up from -3,311.5% several years earlier.

Abion stock price

Access this data via the Eulerpool API

Abion business model & stock analysis

ABION, Inc. engages in the development of biopharmaceuticals for treating incurable diseases. The company is headquartered in Seoul, Seoul. The company went IPO on 2014-07-21. Along with its subsidiaries, the Company operates its business through four segments including product segment, contract research organization (CRO) service segment, research segment and other segment. The Product segment produces and sells diagnostic reagents, research reagents, and stem cell culture medium. The CRO Service segment provides histopathology analysis, molecular genetic analysis, cellular immunoassay, and antibody detection services. The Research segment is engaged in research and development of drugs for protein therapeutics, nucleic acid therapeutics, and antibody therapeutics.

Frequently asked questions about Abion

Converted at the current exchange rate, the Abion share trades at 0.45 EUR (676.00 KRW).

The revenue cannot currently be calculated for Abion.

The profit cannot currently be calculated for Abion.

The P/E ratio cannot be calculated for Abion at the moment.

The P/S cannot be calculated for Abion currently.

The Eulerpool Quality Score for Abion is 2/10.

The ISIN of Abion is KR7203400007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Abion is 203400.KQ. The ticker symbol is used to trade Abion shares on the stock exchange.

Fair ValueTerminal
561.08 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website abionbio.com
Country
South Korea
Currency
KRW
Initial public offering
Jul 21, 2014
ISIN
KR7203400007
Cusip
Y0R0P3100
Market capitalization
34.34 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
0.50
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-40.05 %
Last updated Oct 8, 2026, 6:03 AM

Abion Peer Group

Abion FIGI

203400:KS · BBG006T5N169203400:KQ · BBG006T5N187

All fundamentals and in-depth analysis of Abion

Our stock analysis for Abion stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abion. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.